The Quantellect read.As of Nov 19, 2026, 3 active firms cover Precigen Inc: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $11.00 to $18.00, a moderate spread. The average target of $13.67 sits 222% above the current $4.25. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.14 next quarter toward $0.62 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$13.67
+221.6% upside
Average target across 3 active firms as of Nov 19, 2026 vs $4.25 current
Highest Target$18.00
Average Target$13.67
Lowest Target$11.00
Detailed analyst forecasts for PGEN
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 3 of 3 active firms rate PGEN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PGEN EPS & revenue forecast
EPS · NEXT QUARTER
$0.14
Range $0.11 – $0.17 · 3 analysts · -783% YoY
Next period, 3 analysts expect Precigen Inc to earn $0.14 a share (range $0.11 – $0.17), versus $-0.02 a year earlier. Full-year consensus is $0.24, growing to $0.62 the year after.
REVENUE · NEXT QUARTER
$92.6M
Range $87.5M – $97.7M · 3 analysts · +298% YoY
Revenue is expected to reach $92.6M (range $87.5M – $97.7M), +298.2% year-over-year. Full-year consensus is $240.2M, rising to $442.0M next year.
Top analysts covering Precigen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PGEN.
#1
Jason Butler
JMP Securities · Rank #62
Buy
$11.00+158.8% to target
Overall win rate
49%
+ Follow
#2
Brian Cheng
JP Morgan · Rank #87
Neutral
No targeton PGEN
Overall win rate
51%
+ Follow
#3
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #321
Buy
$18.00+323.5% to target
Overall win rate
38%
+ Follow
#4
JN
Jason N. Butler
Citizens
Buy
$11.00+158.8% to target
Coverage
—
+ Follow
#5
JK
Jennifer Kim
Cantor Fitzgerald
Buy
No targeton PGEN
Coverage
—
+ Follow
PGEN stock forecast FAQ
What is PGEN's average 12-month price target?+
The 3 active firms with a live target average $13.67 for Precigen Inc over the next 12 months, ranging from a $18.00 high to a $11.00 low, as of Nov 19, 2026.
Is PGEN stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for PGEN?+
The Street-high target is $18.00 (HC Wainwright & Co.), and the Street-low is $11.00 (Citizens). The average of all 3 active-firm targets is $13.67.
How many active Wall Street firms cover PGEN?+
3 active firms have a recognized rating on Precigen Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PGEN?+
Among analysts who currently cover PGEN, Jason Butler of JMP Securities has the strongest overall Quantellect track record (Rank #62). Their current call is Buy with a $11.00 target.
What is Precigen Inc's projected EPS for next quarter?+
The consensus estimate is $0.14 per share (range $0.11 – $0.17) across 3 analysts. Full-year EPS is projected at $0.24, rising to $0.62 the following year.
How much revenue is Precigen Inc expected to report next quarter?+
Consensus revenue is $92.6M (range $87.5M – $97.7M). Full-year revenue is projected at $240.2M, growing to $442.0M next year.
Have analysts been upgrading or downgrading PGEN lately?+
As of Nov 19, 2026, 3 of 3 active firms rate PGEN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.